Turtle Creek Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.72M Buy
28,968
+2,215
+8% +$259K 0.2% 86
2026
Q1
$3.22M Buy
26,753
+6,019
+29% +$695K 0.24% 82
2025
Q4
$2.18M Buy
20,734
+5,505
+36% +$517K 0.17% 96
2025
Q3
$1.28M Sell
15,229
-32,584
-68% -$2.68M 0.11% 115
2025
Q2
$3.78M Buy
47,813
+7,335
+18% +$583K 0.45% 62
2025
Q1
$3.63M Buy
40,478
+11,454
+39% +$1.07M 0.54% 58
2024
Q4
$2.89M Sell
29,024
-5,973
-17% -$616K 0.67% 40
2024
Q3
$3.97M Buy
34,997
+1,505
+4% +$179K 0.8% 48
2024
Q2
$4.15M Buy
33,492
+7,140
+27% +$920K 0.96% 41
2024
Q1
$3.48M Buy
26,352
+4,708
+22% +$580K 0.85% 45
2023
Q4
$2.36M Buy
+21,644
New +$2.25M 0.69% 48

Other funds holding MRK

Turtle Creek Wealth Advisors's MRK Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Merck (MRK) stake by 8.3% in Q2 2026, buying an estimated $259K and bringing the position to 28,968 shares worth $3.72M. The position accounts for 0.2% of the portfolio, ranked #86.

Turtle Creek Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.15M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Turtle Creek Wealth Advisors held 28,968 shares of Merck worth $3.72M as of Q2 2026.
  • Turtle Creek Wealth Advisors bought 2,215 Merck shares in Q2 2026, an estimated $259K.
  • Merck made up 0.2% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #86 holding.
  • Turtle Creek Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Turtle Creek Wealth Advisors's Merck position peaked at $4.15M in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.